Skip to main navigation Skip to search Skip to main content

Adenoviral-mediated gene transferinto the canine brain in vivo: Commentary

  • Marianela Candolfi
  • , E. Antonio Chiocca
  • , Kurt Kroeger
  • , G. Elizabeth Pluhar
  • , Josee Bergeron
  • , Mariana Puntel
  • , James Curtin
  • , Elizabeth A. McNiel
  • , Andrew B. Freese
  • , John R. Ohlfest
  • , Peter Moore
  • , Pedro R. Lowenstein
  • , Maria G. Castro

Research output: Contribution to journalComment/debate

Abstract

Glioblastoma multiforme (GBM) is a devastating brain tumor for which there is no cure. Adenoviral-mediated transfer of conditional cytotoxic (herpes simplex virus [HSV] 1-derived thymidine kinase [TK]) and immunostimulatory (Fms-like tyrosine kinase 3 ligand [Flt3L]) transgenes elicited immune-mediated long-term survival in a syngeneic intracranial GBM model in rodents. However, the lack of a large GBM animal model makes it difficult to predict the outcome of therapies in humans. Dogs develop spontaneous GBM that closely resemble the human disease; therefore, they constitute an excellent large animal model. We assayed the transduction efficiency of adenoviral vectors (Ads) encoding β-galactosidase (βGal), TK, and Flt3L in J3T dog GBM cells in vitro and in the dog brain in vivo.
Original languageEnglish
Pages (from-to)178
Number of pages1
JournalNeurosurgery
Volume60
Issue number1
DOIs
Publication statusPublished - Jan 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Adenoviral-mediated gene transferinto the canine brain in vivo: Commentary'. Together they form a unique fingerprint.

Cite this